Medindia
Medindia LOGIN REGISTER
Advertisement

PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress

Tuesday, November 4, 2008 General News
Advertisement
RALEIGH, N.C., Nov. 4 PRA International, a leadingClinical Research Organization announces it will present during thePartnerships in Clinical Trials Congress, 4 - 7 November, 2008 in Berlin,Germany. PRA's Christian Tucat, Senior Vice President of BusinessDevelopment - Europe, will present "What's next in the evolution of CROpartnerships?" at 4PM on Wednesday, 5 November. Drawing on his extensiveexperience, Mr. Tucat will discuss strategic options for governance andSponsor-CRO partnering that optimizes clinical study success.
Advertisement

PRA provides outsourced clinical services across all phases ofpharmaceutical and biotech drug development. It conducts clinical trials inmore than 60 countries across six continents. Operating in Europe for over 27years, PRA has executed over 1,000 studies through its 15 European offices.PRA's capabilities in Europe include:
Advertisement

PRA will have several therapeutic and clinical experts in attendance atthe Partnerships in Clinical Trials Congress, including global leaders ofOncology and Early Development Services.

About PRA International

PRA International is a global Clinical Research Organization providingservices through all phases of clinical development. Although we specialize inOncology, CNS, respiratory/allergy diseases, cardiovascular and infectiousdiseases, we perform studies in all therapeutic areas. PRA has supported over2,100 clinical trials through its 30 global offices. PRA's therapeuticexpertise, global reach, and project experience with local knowledge enableour project teams to deliver consistent and on time performance for ourclients.

To learn more about PRA International, please visithttp://www.prainternational.com, email [email protected] or call ourGlobal Headquarters at +1 (919) 786-8200.-- Clinical operations staff providing coverage of 38 European countries for Phase II through Phase IV studies -- Two 70 bed Phase I units -- An innovative "virtual Phase I" model in central Europe -- A world class bioanalytical laboratory

SOURCE PRA International
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close